Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × poly ICLC × 90 days × Clear all

Sponsor

Conditions

Melanoma 3 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Smoldering Multiple Myeloma 1 Sarcoma 1 Prostatic Neoplasms 1 Osteosarcoma 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Glioblastoma 1 Fibrolamellar hepatocellular carcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Basal Cell 1 Carcinoma 1 Breast Neoplasms 1 Bone Neoplasms 1 Anemia, Refractory 1

Interventions

pembrolizumab 20 enfortumab vedotin 12 Magnetic Resonance Spectroscopy 9 avelumab 8 Specimen Handling 8 Nivolumab 8 Gemcitabine 7 Cisplatin 7 atezolizumab 6 Carboplatin 6 sacituzumab govitecan 4 Ipilimumab 4 Docetaxel 4 durvalumab 3 lenvatinib 2 dodecyl maltoside 2 cabozantinib 2 Paclitaxel 2 Mitomycin 2 Immunoglobulin G 2 Fluorodeoxyglucose F18 2 CTLA-4 Antigen 2 Biopsy 2 ALT-803 2 zimberelimab 1 zanidatamab 1 toripalimab 1 tocilizumab 1 tislelizumab 1 tazemetostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡